A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapy.
Oncoimmunology
; 8(1): e1513440, 2019.
Article
in En
| MEDLINE
| ID: mdl-30546953
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncoimmunology
Year:
2019
Type:
Article
Affiliation country:
United States